by Randy E. Miller | Mar 27, 2024 | FDA, FOIA, Hedge Funds, Law Firms, Litigation, Non-Profits, Pharmaceuticals, Politics, Short-Selling, Stock Market
FOIAengine: Conservative Activists, Law Firms, Non-Profits Signal Competing Agendas A review of the most recent Freedom of Information Act requests made to the Food and Drug Administration illustrates how political organizations, law firms, news media, and financial...
by John A. Jenkins | Mar 6, 2024 | FOIA, Litigation, Short-Selling, Stock Market
FOIAengine Previews an April Fool’s Day Courtrooom Grudge Match This week’s story is about two litigation magnets. One is a household name whose lawsuit against OpenAI dominated the news a few days ago. That would be Elon Musk. The other – Aaron Greenspan –...
by Randy E. Miller | Feb 14, 2024 | FDA, FOIA, Hedge Funds, Litigation, Pharmaceuticals, Short-Selling, Stock Market
FOIAengine Breaks Down the Action Financial firms are continuing to monitor many of the pharmaceutical manufacturers we’ve reported on in recent months, including Krystal Biotech, Apellis Pharmaceuticals, Establishment Labs, Catalent and Astellas. That’s according to...
by John A. Jenkins | Feb 7, 2024 | FOIA, FTC, Litigation
FOIAengine: Who’s Asking What, and Why? Days after the Federal Trade Commission launched an investigation of the five biggest players in artificial intelligence, Lina Khan was on a charm offensive aimed at winning the confidence of her biggest enemies on Wall...
by Randy E. Miller | Jan 24, 2024 | FDA, FOIA, Law Firms, Litigation, Pharmaceuticals
In FOIAengine, a Law Firm’s Strategy Takes Shape When we tallied the hundreds of thousands of Freedom of Information Act requests filed with the federal government last year, one law firm stood out. According to PoliScio Analytics’ competitive-intelligence database...
by John A. Jenkins | Jan 10, 2024 | Antitrust, FOIA, FTC, Law Firms, Litigation
Requests in FOIAengine Show Groups Watching the FTC When the Federal Trade Commission joined the Justice Department last month in announcing new merger guidelines, two years in the making, the revised rules of the road were a warning to acquisitive corporations: ...
